Avidity Biosciences Inc (RNA)
30.21
-0.58
(-1.88%)
USD |
NASDAQ |
Jan 08, 13:02
Avidity Biosciences Research and Development Expense (Annual): 190.97M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Vertex Pharmaceuticals Inc | 3.69B |
| Sarepta Therapeutics Inc | 877.39M |
| Dyne Therapeutics Inc | 210.76M |
| Entrada Therapeutics Inc | 99.88M |
| Catalyst Pharmaceuticals Inc | 93.15M |